Ashbury, Australia

Trevor William Hambley

USPTO Granted Patents = 1 


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Trevor William Hambley

Introduction

Trevor William Hambley is a notable inventor based in Ashbury, Australia. He has made significant contributions to the field of medical treatment, particularly in the area of oncology. His innovative approach to treating solid tumors has garnered attention in the scientific community.

Latest Patents

Hambley's most recent patent is titled "Method for the treatment of a solid tumour." This invention relates to a method of treating a neoplastic condition and to agents useful for the same. More specifically, it focuses on facilitating the treatment of a solid tumor in a localized manner through the co-administration of particulate material and a cellular toxin. This method is applicable in various therapeutic treatments, including the management of primary and metastatic tumors. He holds 1 patent for this groundbreaking work.

Career Highlights

Trevor William Hambley is associated with the University of Sydney Commercial Development & Industry Partnerships. His role at this esteemed institution allows him to engage in research and development that bridges the gap between academia and industry. His work is instrumental in advancing medical technologies and improving patient outcomes.

Collaborations

Hambley has collaborated with several professionals in his field, including Brian Stanley Hawkett and Nicole Sarah Bryce. These partnerships enhance the scope and impact of his research, fostering innovation in medical treatments.

Conclusion

Trevor William Hambley's contributions to the field of oncology through his innovative patent demonstrate his commitment to improving cancer treatment methodologies. His work continues to inspire advancements in medical science and offers hope for better therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…